Beginning Cash: The amount of cash reported by the company on its previous statement.
Travere Therapeutics, Inc. (TVTX) had Beginning Cash of $61.69M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$145.24M |
|
$-111.40M |
|
$11.45M |
|
$133.79M |
|
$533.38M |
|
$-388.14M |
|
$12.03M |
|
$-376.11M |
|
$-376.11M |
|
$-376.33M |
|
$-376.33M |
|
$-111.40M |
|
$-376.33M |
|
$-388.14M |
|
$-355.35M |
|
74.27M |
|
74.27M |
|
$-1.50 |
|
$-1.50 |
|
| Balance Sheet Financials | |
$616.77M |
|
$7.48M |
|
$172.14M |
|
$788.91M |
|
$177.91M |
|
$377.26M |
|
$410.19M |
|
$588.10M |
|
$200.81M |
|
$96.37M |
|
$200.81M |
|
75.37M |
|
| Cash Flow Statement Financials | |
$-280.02M |
|
$55.78M |
|
$218.75M |
|
|
Beginning Cash |
$61.69M |
$58.18M |
|
$-3.51M |
|
$44.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.47 |
|
-- |
|
-- |
|
0.65 |
|
1.88 |
|
92.12% |
|
-267.24% |
|
-267.24% |
|
-244.66% |
|
-258.96% |
|
-76.70% |
|
$-280.69M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
1.22 |
|
6.86 |
|
53.23 |
|
-187.41% |
|
-390.52% |
|
-47.70% |
|
-65.10% |
|
$2.66 |
|
$-3.78 |
|
$-3.77 |
|